Greatmark Investment Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.24M | Sell |
36,732
-1,230
| -3% | -$265K | 1.02% | 29 |
|
|
2026
Q1 | $8.26M | Sell |
37,962
-730
| -2% | -$162K | 0.97% | 31 |
|
|
2025
Q4 | $8.84M | Sell |
38,692
-1,128
| -3% | -$257K | 1.05% | 30 |
|
|
2025
Q3 | $9.22M | Sell |
39,820
-1,290
| -3% | -$263K | 1.11% | 27 |
|
|
2025
Q2 | $7.63M | Sell |
41,110
-170
| -0.4% | -$31.6K | 0.96% | 32 |
|
|
2025
Q1 | $8.65M | Buy |
41,280
+80
| +0.2% | +$15.6K | 1.18% | 27 |
|
|
2024
Q4 | $7.32M | Buy |
41,200
+1,685
| +4% | +$310K | 1% | 30 |
|
|
2024
Q3 | $7.8M | Sell |
39,515
-190
| -0.5% | -$35.5K | 1.06% | 29 |
|
|
2024
Q2 | $6.81M | Sell |
39,705
-255
| -0.6% | -$42.2K | 0.99% | 31 |
|
|
2024
Q1 | $7.28M | Sell |
39,960
-970
| -2% | -$167K | 1.03% | 30 |
|
|
2023
Q4 | $6.34M | Sell |
40,930
-1,223
| -3% | -$178K | 0.99% | 31 |
|
|
2023
Q3 | $6.28M | Sell |
42,153
-150
| -0.4% | -$22K | 1.11% | 31 |
|
|
2023
Q2 | $5.7M | Sell |
42,303
-2,425
| -5% | -$356K | 0.96% | 30 |
|
|
2023
Q1 | $7.13M | Sell |
44,728
-1,770
| -4% | -$271K | 1.27% | 27 |
|
|
2022
Q4 | $7.51M | Sell |
46,498
-2,255
| -5% | -$346K | 1.37% | 28 |
|
|
2022
Q3 | $6.54M | Sell |
48,753
-192
| -0.4% | -$27.6K | 1.26% | 28 |
|
|
2022
Q2 | $7.5M | Sell |
48,945
-1,023
| -2% | -$156K | 1.44% | 26 |
|
|
2022
Q1 | $8.1M | Sell |
49,968
-125
| -0.2% | -$18.2K | 1.33% | 25 |
|
|
2021
Q4 | $6.78M | Sell |
50,093
-1,275
| -2% | -$151K | 1.14% | 27 |
|
|
2021
Q3 | $5.54M | Sell |
51,368
-1,385
| -3% | -$158K | 1.04% | 29 |
|
|
2021
Q2 | $5.94M | Sell |
52,753
-425
| -0.8% | -$47.9K | 1.07% | 30 |
|
|
2021
Q1 | $5.75M | Sell |
53,178
-2,195
| -4% | -$235K | 1.12% | 29 |
|
|
2020
Q4 | $5.93M | Sell |
55,373
-835
| -1% | -$80.2K | 1.28% | 27 |
|
|
2020
Q3 | $4.92M | Sell |
56,208
-1,225
| -2% | -$115K | 1.24% | 28 |
|
|
2020
Q2 | $5.64M | Sell |
57,433
-5,285
| -8% | -$465K | 1.49% | 25 |
|
|
2020
Q1 | $4.78M | Buy |
62,718
+1,190
| +2% | +$101K | 1.54% | 21 |
|
|
2019
Q4 | $5.45M | Buy |
61,528
+2,830
| +5% | +$235K | 1.35% | 27 |
|
|
2019
Q3 | $4.45M | Buy |
58,698
+6,710
| +13% | +$460K | 1.22% | 28 |
|
|
2019
Q2 | $3.78M | Buy |
51,988
+23,300
| +81% | +$1.83M | 1.13% | 27 |
|
|
2019
Q1 | $2.31M | Sell |
28,688
-265
| -0.9% | -$21.7K | 0.73% | 36 |
|
|
2018
Q4 | $2.67M | Sell |
28,953
-3,200
| -10% | -$281K | 0.96% | 33 |
|
|
2018
Q3 | $3.04M | Buy |
32,153
+620
| +2% | +$58.8K | 0.96% | 34 |
|
|
2018
Q2 | $2.92M | Hold |
31,533
| – | – | 1.01% | 32 |
|
|
2018
Q1 | $2.98M | Sell |
31,533
-730
| -2% | -$80.2K | 1.09% | 30 |
|
|
2017
Q4 | $3.12M | Sell |
32,263
-1,975
| -6% | -$186K | 1.13% | 29 |
|
|
2017
Q3 | $3.04M | Sell |
34,238
-940
| -3% | -$71.6K | 1.16% | 29 |
|
|
2017
Q2 | $2.55M | Buy |
35,178
+1,242
| +4% | +$83.5K | 1.02% | 30 |
|
|
2017
Q1 | $2.21M | Buy |
33,936
+560
| +2% | +$35.2K | 0.91% | 32 |
|
|
2016
Q4 | $2.09M | Sell |
33,376
-1,410
| -4% | -$86.1K | 0.88% | 33 |
|
|
2016
Q3 | $2.19M | Buy |
34,786
+1,185
| +4% | +$76.7K | 0.95% | 32 |
|
|
2016
Q2 | $2.08M | Buy |
33,601
+3,610
| +12% | +$220K | 0.93% | 33 |
|
|
2016
Q1 | $1.71M | Buy |
29,991
+12,390
| +70% | +$691K | 0.78% | 38 |
|
|
2015
Q4 | $1.04M | Hold |
17,601
| – | – | 0.46% | 47 |
|
|
2015
Q3 | $958K | Sell |
17,601
-900
| -5% | -$58.6K | 0.44% | 49 |
|
|
2015
Q2 | $1.24M | Sell |
18,501
-932
| -5% | -$60.8K | 0.53% | 44 |
|
|
2015
Q1 | $1.14M | Hold |
19,433
| – | – | 0.49% | 48 |
|
|
2014
Q4 | $1.27M | Sell |
19,433
-375
| -2% | -$23.6K | 0.54% | 49 |
|
|
2014
Q3 | $1.14M | Sell |
19,808
-355
| -2% | -$19.7K | 0.53% | 47 |
|
|
2014
Q2 | $1.14M | Hold |
20,163
| – | – | 0.48% | 50 |
|
|
2014
Q1 | $1.04M | Hold |
20,163
| – | – | 0.46% | 51 |
|
|
2013
Q4 | $1.06M | Sell |
20,163
-1,135
| -5% | -$55.8K | 0.5% | 48 |
|
|
2013
Q3 | $953K | Buy |
21,298
+275
| +1% | +$12.2K | 0.5% | 49 |
|
|
2013
Q2 | $869K | Buy |
+21,023
| New | +$919K | 0.56% | 47 |
|
Other funds holding ABBV
Greatmark Investment Partners's ABBV Position: Q2 2026 in Review
Greatmark Investment Partners reduced its AbbVie (ABBV) stake by 3.2% in Q2 2026, selling an estimated $265K and leaving 36,732 shares worth $9.24M. The position accounts for 1.02% of the portfolio, ranked #29.
Greatmark Investment Partners first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Greatmark Investment Partners held 36,732 shares of AbbVie worth $9.24M as of Q2 2026.
- Greatmark Investment Partners sold 1,230 AbbVie shares in Q2 2026, an estimated $265K.
- AbbVie made up 1.02% of Greatmark Investment Partners's portfolio in Q2 2026, its #29 holding.
- Greatmark Investment Partners first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Greatmark Investment Partners's 13F filing for Q2 2026, filed 24 Jul 2026.